27 research outputs found

    Early Interactions of Murine Macrophages with Francisella tularensis Map to Mouse Chromosome 19

    Get PDF
    ABSTRACT Differences among individuals in susceptibility to infectious diseases can be modulated by host genetics. Much of the research in this field has aimed to identify loci within the host genome that are associated with these differences. In mice, A/J (AJ) and C57BL/6J (B6) mice show differential susceptibilities to various pathogens, including the intracellular pathogen Francisella tularensis. Because macrophages are the main initial target during F. tularensis infection, we explored early interactions of macrophages from these two mouse strains with F. tularensis as well as the genetic factors underlying these interactions. Our results indicate that bacterial interactions with bone marrow-derived macrophages (BMDMs) during early stages of infection are different in the AJ and B6 strains. During these early stages, bacteria are more numerous in B6 than in AJ macrophages and display differences in trafficking and early transcriptional response within these macrophages. To determine the genetic basis for these differences, we infected BMDMs isolated from recombinant inbred (RI) mice derived from reciprocal crosses between AJ and B6, and we followed early bacterial counts within these macrophages. Quantitative trait locus (QTL) analysis revealed a locus on chromosome 19 that is associated with early differences in bacterial counts in AJ versus B6 macrophages. QTL analysis of published data that measured the differential susceptibilities of the same RI mice to an in vivo challenge with F. tularensis confirmed the F. tularensis susceptibility QTL on chromosome 19. Overall, our results show that early interactions of macrophages with F. tularensis are dependent on the macrophage genetic background

    Transmembrane domains interactions within the membrane milieu: Principles, advances and challenges

    Get PDF
    AbstractProtein–protein interactions within the membrane are involved in many vital cellular processes. Consequently, deficient oligomerization is associated with known diseases. The interactions can be partially or fully mediated by transmembrane domains (TMD). However, in contrast to soluble regions, our knowledge of the factors that control oligomerization and recognition between the membrane–embedded domains is very limited. Due to the unique chemical and physical properties of the membrane environment, rules that apply to interactions between soluble segments are not necessarily valid within the membrane. This review summarizes our knowledge on the sequences mediating TMD–TMD interactions which include conserved motifs such as the GxxxG, QxxS, glycine and leucine zippers, and others. The review discusses the specific role of polar, charged and aromatic amino acids in the interface of the interacting TMD helices. Strategies to determine the strength, dynamics and specificities of these interactions by experimental (ToxR, TOXCAT, GALLEX and FRET) or various computational approaches (molecular dynamic simulation and bioinformatics) are summarized. Importantly, the contribution of the membrane environment to the TMD–TMD interaction is also presented. Studies utilizing exogenously added TMD peptides have been shown to influence in vivo the dimerization of intact membrane proteins involved in various diseases. The chirality independent TMD–TMD interactions allows for the design of novel short d- and l-amino acids containing TMD peptides with advanced properties. Overall these studies shed light on the role of specific amino acids in mediating the assembly of the TMDs within the membrane environment and their contribution to protein function. This article is part of a Special Issue entitled: Protein Folding in Membranes

    Glycoconjugate vaccine using a genetically modified O antigen induces protective antibodies to Francisella tularensis

    No full text
    : Francisella tularensis is the causative agent of tularemia, a category A bioterrorism agent. The lipopolysaccharide (LPS) O antigen (OAg) of F. tularensis has been considered for use in a glycoconjugate vaccine, but conjugate vaccines tested so far have failed to confer protection necessary against aerosolized pulmonary bacterial challenge. When F. tularensis OAg was purified under standard conditions, the antigen had a small molecular size [25 kDa, low molecular weight (LMW)]. Using milder extraction conditions, we found the native OAg had a larger molecular size [80 kDa, high molecular weight (HMW)], and in a mouse model of tularemia, a glycoconjugate vaccine made with the HMW polysaccharide coupled to tetanus toxoid (HMW-TT) conferred better protection against intranasal challenge than a conjugate made with the LMW polysaccharide (LMW-TT). To further investigate the role of OAg size in protection, we created an F. tularensis live vaccine strain (LVS) mutant with a significantly increased OAg size [220 kDa, very high molecular weight (VHMW)] by expressing in F. tularensis a heterologous chain-length regulator gene (wzz) from the related species Francisella novicida Immunization with VHMW-TT provided markedly increased protection over that obtained with TT glycoconjugates made using smaller OAgs. We found that protective antibodies recognize a length-dependent epitope better expressed on HMW and VHMW antigens, which bind with higher affinity to the organism

    Specific subsets of colonic APCs are modulated by IFNAR1 signaling during <i>Salmonella</i> infection.

    No full text
    <p>Cells were isolated from the colonic lamina propria of uninfected mice (CTRL) or infected mice on day 3 after oral infection with 10<sup>4</sup> CFU <i>Salmonella</i> (SAL). (A) Gating strategy to identify macrophages and cDCs. (B) Numbers of total, CD11c<sup>+</sup>, and CD11c<sup>-</sup> colonic macrophages in WT and <i>Ifnar1</i><sup><i>-/-</i></sup> mice. (C) Numbers of total, CD103<sup>+</sup>, and CD103<sup>-</sup> colonic cDCs in WT and <i>Ifnar1</i><sup><i>-/-</i></sup> mice. Results are mean values ± SD. Statistical analysis was performed with the Mann-Whitney test. ns, not significant; *<i>p</i><0.05; **<i>p</i><0.005.</p

    IFNAR1 signaling is associated with a decrease in IL-10R<sup>+</sup> colonic APCs in <i>Salmonella</i>-infected mice.

    No full text
    <p>(A-B) Cells were isolated from the colonic lamina propria of uninfected mice (CTRL) or on day 3 post-infection from mice orally infected with 10<sup>4</sup> CFU <i>Salmonella</i> (SAL). (A) The number of IL-10R<sup>+</sup> colonic macrophages, CD11c<sup>+</sup> IL-10R<sup>+</sup>, and CD11c<sup>-</sup> IL-10R<sup>+</sup> macrophages were enumerated in WT and <i>Ifnar1</i><sup><i>-/-</i></sup> mice. (B) The number of total IL-10R<sup>+</sup> cDCs, CD103<sup>+</sup> IL-10R<sup>+</sup> cDCs, and CD103<sup>-</sup> IL-10R<sup>+</sup> cDCs were enumerated in WT and <i>Ifnar1</i><sup><i>-/-</i></sup> mice. Results represent the mean with SD. Statistical analysis was performed using the Mann-Whitney test. *p<0.05, **p<0.005. (C) Survival curve of WT and <i>Ifnar1</i><sup><i>-/-</i></sup> mice treated with anti-IL-10R mAb (anti-IL-10R) or isotype control antibody (isotype) on days -3, 0, and +3 and infected with 10<sup>4</sup> CFU <i>Salmonella</i>. Statistical analysis was performed using a log-rank test. ns, not significant; *p<0.05.</p
    corecore